Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

被引:28
作者
Wingate, Jonathan T. [1 ]
Brandenberger, Jared [2 ]
Weiss, Andrew [3 ]
Scovel, Lauren G. [2 ]
Kuhr, Christian S. [2 ]
机构
[1] Madigan Army Med Ctr, Dept Urol, Tacoma, WA 98431 USA
[2] Virginia Mason Med Ctr, Dept Urol & Renal Transplantat, Seattle, WA 98101 USA
[3] Virginia Mason Med Ctr, Dept Nephrol & Renal Transplantat, Seattle, WA 98101 USA
关键词
bacteriuria; BK nephropathy; BK viremia; ureteral stent; URINARY-TRACT-INFECTION; SINGLE-CENTER EXPERIENCE; UROLOGICAL COMPLICATIONS; RENAL-TRANSPLANTATION; NEPHROPATHY; IMPACT; RECIPIENTS; VIRUS;
D O I
10.1111/tid.12644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesUreteral stents are used in kidney transplantation (KTX) to decrease post-operative complications, but they are associated with BK polyomavirus viremia (BKV). Our primary outcome was to determine the association between ureteral stent duration and BKV. Secondary outcome measures were the association between bacteriuria and stent duration or use of ureteral stent strings. MethodsBetween January 2010 and January 2015, 403 patients underwent KTX at the Virginia Mason Medical Center and met inclusion criteria. Stent duration was classified as short (<3weeks) or long (>3weeks). Multivariate logistic regression models were created to assess for factors associated with BKV. The covariates in the BKV model were chosen a priori based on stent duration and risk factors previously described in the literature. ResultsUreteral stents were placed in 304 (75.4%) transplants. Stent strings were left attached in 166 (54.6%) patients. On multivariate analyses, long stent duration was significantly associated with increased risk of BKV compared with no stent (odds ratio [OR] 1.92, P=.044, 95% confidence interval [CI] 1.04-3.74). Short stent duration was not associated with BKV. Sixty-two (15.4%) patients had bacteriuria. Bacteriuria was associated with female gender (OR 2.77, P<.001, 95% CI 1.58-4.95), and there was a dose-dependent effect with stent duration compared with no stentshort duration (OR 2.46, P=.049, 95% CI 1.05-6.49) and long duration (OR 3.58, P=.004, 95% CI 1.58-9.25). Stent strings were not associated with either complication. ConclusionsThe association between ureteral stents and BKV may be dose dependent.
引用
收藏
页数:5
相关论文
共 17 条
  • [1] Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: a randomized clinical trial
    Andres Garcia-Perdomo, Herney
    Lopez, Hugo
    Carbonell, Jorge
    Castillo, Diego
    Guillermo Catano, Juan
    Seron, Pamela
    [J]. WORLD JOURNAL OF UROLOGY, 2013, 31 (06) : 1433 - 1439
  • [2] Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction
    Brennan, DC
    Agha, I
    Bohl, DL
    Schnitzler, MA
    Hardinger, HL
    Lockwood, M
    Torrence, S
    Schuessler, R
    Roby, T
    Gaudreault-Keener, M
    Storch, GA
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 582 - 594
  • [3] Ureteral Stents Are Associated With Reduced Risk of Ureteral Complications After Kidney Transplantation: A Large Single Center Experience
    Fayek, Sameh A.
    Keenan, Jeffrey
    Haririan, Abdolreza
    Cooper, Matthew
    Barth, Rolf N.
    Schweitzer, Eugene
    Bromberg, Jonathan S.
    Bartlett, Stephen T.
    Philosophe, Benjamin
    [J]. TRANSPLANTATION, 2012, 93 (03) : 304 - 308
  • [4] Polyomavirus BK replication dynamics In vivo and In silico to predict cytopathology and viral clearance in kidney transplants
    Funk, G. A.
    Gosert, R.
    Comoli, P.
    Ginevri, F.
    Hirsch, H. H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2368 - 2377
  • [5] Impact of Ureteral Stenting on Urological Complications After Kidney Transplantation Surgery: A Single-Center Experience
    Harza, M.
    Baston, C.
    Preda, A.
    Olaru, V.
    Ismail, G.
    Domnisor, L.
    Daia, D.
    Mitroi, I.
    Baston, M. O.
    Sinescu, I.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3459 - 3462
  • [6] Hashim F, 2014, J TRANSPLANT, V2014, P1
  • [7] BK virus: Opportunity makes a pathogen
    Hirsch, HH
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) : 354 - 360
  • [8] Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations
    Hirsch, HH
    Brennan, DC
    Drachenberg, CB
    Ginevri, F
    Gordon, J
    Limaye, AP
    Mihatsch, MJ
    Nickeleit, V
    Ramos, E
    Randhawa, P
    Shapiro, R
    Steiger, J
    Suthanthiran, M
    Trofe, J
    [J]. TRANSPLANTATION, 2005, 79 (10) : 1277 - 1286
  • [9] Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
    Hooton, Thomas M.
    Bradley, Suzanne F.
    Cardenas, Diana D.
    Colgan, Richard
    Geerlings, Suzanne E.
    Rice, James C.
    Saint, Sanjay
    Schaeffer, Anthony J.
    Tambayh, Paul A.
    Tenke, Peter
    Nicolle, Lindsay E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (05) : 625 - 663
  • [10] Ureteral stent placement and BK viremia in kidney transplant recipients
    Kayler, L.
    Zendejas, I.
    Schain, D.
    Magliocca, J.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (02) : 202 - 207